Dear Ma'am and Sirs: We are having training on multiplex (10 beads) cytokine flow analysis of Th1/Th2 shift by treatment vs placebo (human). We will measure the baseline serum cytokine profiles as well as supernatants of isolated PBL or PBMC stimulated by PHA. Does anyone have opinions about the use of autologous serum vs. FBS for the ex vivo study? As we hypothesize the baseline serum of the treatment group to be shifted to either Th1 or Th2, the use of autologous serum seems to make more sense than making this variable constant (FBS). Any opinions about autologous serum or multiplex beads analysis will be appreciated. I will try to summarize feedbacks, but these two may have to be separate questions. In health, Masa Sasagawa, ND Naturopathic Physician - Washington Affiliate Assistant Professor - University of Washington School of Nursing, Dept of Biobehavioral Nursing and Health Systems Postdoctoral Research Fellow - Bastyr University 14500 Juanita Dr NE, #472 Kenmore, WA 98028 Phone: 425-602-3178 Fax: 425-602-3079 masas@bastyr.eduReceived on Tue Dec 13 11:58:00 2005
This archive was generated by hypermail 2.1.8 : Sat Jan 14 2006 - 22:04:00 EST